Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children.
Human papillomavirus (HPV) causes disease not only in the genital tract, but also in the larynx. Within the larynx HPV 6/11 causes recurrent respiratory papillomatosis (RRP). RRP is relatively uncommon, yet it is devastating for the patient who requires many surgical procedures over years to control it. The cost of HPV-related genital tract disease is thought to be around pound31 million per annum, whereas RRP costs in the region of pound4 million annually despite RRP being comparatively rare. The HPV vaccination programme has brought great hope, although it is unfortunate that the current UK programme only targets high-risk HPV. Targeting both low- and high-risk HPV would have had additional benefits for the UK.
Donne
A J
AJ
University of Liverpool, UK. Adam.Donne@alderhey.nhs.uk
Clarke
R
R
D002648:Child; D017281:Cost of Illness; D006801:Humans; D007822:Laryngeal Neoplasms / Q000191:economics / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery; D010212:Papilloma / Q000191:economics / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery; D053918:Papillomavirus Vaccines / Q000276:immunology*; D012008:Recurrence; D014611:Vaccination
D053918:Papillomavirus Vaccines